中教控股(00839.HK)部分贖回於2024年到期可換股債
格隆匯3月9日丨中教控股(00839.HK)公吿,有關發行於2024年到期23.55億港元2.0釐可換股債券,據可換股債券條款及條件及接獲受託人通知,公司將根據可換股債券持有人的選擇於2022年3月28日按面值贖回本金為15.44億港元可換股債券。公司將以內部資源撥付相關贖回。相關可換股債券於贖回後將會註銷並不可再轉換為公司股份。
同公司早前已購回並註銷的本金為6.92億港元可換股債券,於贖回日期總計將贖回的可換股債券佔原先發行可換股債券本金總額約94.95%。
於贖回日期後,剩餘本金為1.19億港元可換股債券將於2024年3月到期,佔原先發行可換股債券本金總額約5.05%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.